Spotlight
Newly Published Preclinical Data Demonstrate the Potential of IONIS-KRAS-2.5Rx in Cancer
More »
Nature Communications Publishes Preclinical Results Evaluating Antisense Drugs Targeting DNM2 for the Treatment of Centronuclear Myopathy
More »
Newly Published Data Characterizes the Burden of Disease in Patients with Familial Chylomicronemia Syndrome
More »
Ionis Pharmaceuticals’ CEO, Dr. Stanley Crooke, Receives E. B. Hershberg Award from the American Chemical Society
More »
Clinical Trials
We have numerous ongoing clinical trials designed to evaluate our drugs in a variety of health conditions. More »
